Carisma Therapeutics, Inc. (CARM)
NASDAQ: CARM · IEX Real-Time Price · USD
6.38
+0.53 (9.06%)
At close:
Jun 2, 2023, 4:00 PM
6.25
-0.13 (-2.04%)
After-hours:
Jun 2, 2023, 6:21 PM EDT
Carisma Therapeutics Market Cap
Carisma Therapeutics has a market cap or net worth of $256.82 million as of June 2, 2023. Its market cap has increased by 147.18% in one year.
Market Cap
256.82M
Enterprise Value
123.30M
1-Year Change
147.18%
Ranking
Category
Stock Price
$6.38
Market Cap Chart
Since February 6, 2014, Carisma Therapeutics's market cap has increased from $159.40M to $256.82M, an increase of 61.12%. That is a compound annual growth rate of 5.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 1, 2023 | 235.50M | 3.20% |
| May 31, 2023 | 228.20M | 13.59% |
| May 30, 2023 | 200.90M | -3.65% |
| May 26, 2023 | 208.50M | 7.92% |
| May 25, 2023 | 193.20M | -8.39% |
| May 24, 2023 | 210.90M | - |
| May 23, 2023 | 210.90M | 6.68% |
| May 22, 2023 | 197.70M | 6.52% |
| May 19, 2023 | 185.60M | - |
| May 18, 2023 | 185.60M | -5.31% |
| May 17, 2023 | 196.00M | 1.03% |
| May 16, 2023 | 194.00M | -4.39% |
| May 15, 2023 | 202.90M | -1.93% |
| May 12, 2023 | 206.90M | -9.01% |
| May 11, 2023 | 227.40M | 281.54% |
| May 10, 2023 | 59.60M | -10.64% |
| May 9, 2023 | 66.70M | 7.93% |
| May 8, 2023 | 61.80M | 9.57% |
| May 5, 2023 | 56.40M | 8.67% |
| May 4, 2023 | 51.90M | 6.79% |
| May 3, 2023 | 48.60M | 13.29% |
| May 2, 2023 | 42.90M | 2.39% |
| May 1, 2023 | 41.90M | -0.71% |
| Apr 28, 2023 | 42.20M | 2.68% |
| Apr 27, 2023 | 41.10M | 0.98% |
View and export this data all the way back to 2014.
Start Free Trial.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| VectivBio Holding AG | 1.04B |
| Sorrento Therapeutics, Inc. | 169.08M |
| AVROBIO, Inc. | 48.52M |
| eFFECTOR Therapeutics, Inc. | 39.43M |
| Hepion Pharmaceuticals, Inc. | 36.59M |
| Immix Biopharma, Inc. | 30.37M |
| Zura Bio Limited | 28.98M |
| Palisade Bio, Inc. | 8.84M |
| Enveric Biosciences, Inc. | 8.71M |
| CNS Pharmaceuticals, Inc. | 7.62M |
| ZyVersa Therapeutics, Inc. | 7.40M |
| Altamira Therapeutics Ltd. | 5.80M |